EDMONTON, ALBERTA--(Marketwired - Aug. 24, 2016) - Radient Technologies Inc. ("Radient" or the "Corporation") (TSX VENTURE:RTI) is pleased to announce the appointment of Mr. Jith Veeravalli to its Board of Directors as an independent, non-executive director.
Jith Veeravalli is a successful entrepreneur and over the past 35 years has operated businesses in numerous countries. As Chairman of Gencor Pacific Limited ("Gencor"), a private life sciences product development company, based in California and Hong Kong, he has been instrumental in its rise to prominence among the nutraceutical companies worldwide. Over the past 10 years he has made strategic investment in technology companies and sits on the board of several companies in the US, Canada, Australia, Israel, South Africa, Hong Kong and India.
Gencor and Radient established a strategic partnership in 2014 that also included a strategic investment by Gencor. Jith replaces Mr. Rasamay Venkatesh who was previously Gencor's representative. Mr. Venkatesh will be stepping down from the Board effectively immediately.
"On behalf of the Board of Directors and management, I would like to welcome Jith to the Radient Board. Gencor is an important partner for the Company and we highly value our relationship. Jith's wealth of industry experience will be invaluable for the next stage of growth for the Company," said Denis Taschuk, President and CEO of Radient.
Radient extracts natural compounds from a range of biological materials using microwave assisted processing ("MAP™"), a patented technology platform which provides superior customer outcomes in terms of ingredient purity, yield, and cost. From its 20,000 square foot manufacturing plant in Edmonton, Alberta, Radient serves market leaders in industries that include pharmaceutical, food, beverage, natural health, personal care and biofuel markets. Visit www.radientinc.com for more information.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.